Table 4.
Variables | Remission Status | OR | |
---|---|---|---|
No Remission and relapse N (%) |
Remission N (%) |
||
CNA | |||
Negative | 19 (39.6%) | 29 (60.4%) | 1,048 |
Positive | 10 (38.5%) | 16 (61.5%) | |
No. of CNAs | |||
3 or more CNAs | 5 (50.0%) | 5 (50.0%) | 0.890 |
2 CNAs | 5 (38.5%) | 8 (61.5%) | |
1 CNA | 2 (33.3%) | 4 (66.7%) | |
No CNA | 17 (37.8%) | 28 (62.2%) | |
Gene mutation PAX5 | |||
Yes | 8 (66.7%) | 4 (33.3%) | 3.906 |
No | 21 (33.9%) | 41 (66.1%) | |
CDKN2A/2B | |||
No | 23 (35.4%) | 42 (64.6%) | 0.274 |
Yes | 6 (66.7%) | 3 (33.3%) | |
PAR1 Region | |||
No | 27 (41.5%) | 38 (58.5%) | 2.487 |
Yes | 2 (22.2%) | 7 (77.8%) | |
ETV6 | |||
No | 27 (39.7%) | 41 (60.3%) | 1.317 |
Yes | 2 (33.3%) | 4 (66.7%) | |
IKZF1 | |||
No | 26 (37.7%) | 43 (62.3%) | 0.403 |
Yes | 3 (60.0%) | 2 (40.0%) | |
BTG1 | |||
No | 27 (38.6%) | 43 (61.4%) | 0.628 |
Yes | 2 (50.0%) | 2 (50.0%) | |
RB1 | |||
No | 29 (40.8%) | 42 (59.2%) | 0.275 |
Yes | 0 (0.0%) | 3 (100.0%) |